Nabriva Therapeutics plc
NBRVF0.00010.00% ( 0.0000 )
Nabriva Therapeutics plc (NBRVF)
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infectio...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 0.0001
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 0.0002
- Volume Ratio
- 0.00
- Turnover Ratio
- --
Nabriva Therapeutics plc Analyst Rating
View MoreForecast & Rating
Mar 27, 2023Price forecast
$1.00999900.00%
Forecast & RatingSell
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell100.00%
News
- StockTitan · May 11 at 09:30 PM
Keenova Reports First Quarter 2026 Financial Results | MNK Stock News
- StockTitan · May 3 at 10:30 PM
Keenova Launches New Consumer Campaign for Dupuytren's Contracture: Don't Be a Viking | MNK Stock News
- StockTitan · Apr 30 at 10:30 PM
Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at Digestive Disease Week | MNK Stock News
- prnewswire · Mar 31 at 05:30 AM
06:30 ETKeenova Announces Unaudited Fourth Quarter 2025 Financial Results
- StockTitan · Mar 26 at 10:30 PM
Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at the SHM Converge | MNK Stock News
- London Stock Exchange · Feb 26 at 02:00 AM
REG - AIM - AIM Notice - 26/02/2026
